Richard Pops serves as Chairman and Chief Executive Officer of Alkermes, a fully-integrated, global biopharmaceutical company developing innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction and cancer.
With the headlines focused on COVID-19, many may have forgotten about the escalating epidemic of substance use disorder. National Recovery Month is a time to bring this issue back to the top of the agenda, raise awareness, and drive action, writes Richard Pops, CEO of Alkermes.
Published: September 27th 2021 | Updated:
